Lipella Pharmaceuticals Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Lipella Pharmaceuticals Inc
Access all reports
Lipella Pharmaceuticals Inc is a U.S.-based clinical-stage biopharmaceutical company focused on developing therapies for urologic and other rare diseases. The company specializes in the reformulation and delivery of existing drugs using proprietary technology to treat conditions such as interstitial cystitis, hemorrhagic cystitis, and other bladder-related disorders. Lipella conducts research and clinical trials to advance its drug candidates through regulatory pathways. The company is headquartered in Pittsburgh, Pennsylvania, and its shares are listed on the CSE.
Key slides for Lipella Pharmaceuticals Inc
Corporate Presentation
Lipella Pharmaceuticals Inc
Corporate Presentation
Lipella Pharmaceuticals Inc
Latest articles
)
Moncler: From the Mountains to the Runway
The story of Moncler, all the way from its beginnings in the Alps to its journey to some of the most prestigious runways in the world.
16 Apr 2025
)
eToro: Innovation, Growth, and IPO Plans
eToro was founded in 2007 and has grown into a global trading platform with over 40 million users and an extensive offering across several asset classes.
10 Apr 2025
)
Yum! Brands: The Company Behind Pizza Hut, KFC, and Taco Bell
Yum! Brands started at PepsiCo in the 1970s and is home to some of the most well-known brands in the world, such as Pizza Hut, KFC, and Taco Bell.
9 Apr 2025
Ticker symbol
LIPO
Country
🇺🇸 United States